YKL050C Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Overview

YKL050C Antibody (Product Code: CSB-PA339581XA01SVG) is a rabbit-derived polyclonal antibody raised against the recombinant YKL050C protein . It specifically recognizes the YKL050C gene product, a peroxisomal matrix protein recently identified as a lipase named Lpx2 (Lipase of Peroxisomes 2) .

Key Discoveries

  • Peroxisomal Localization: YKL050C (Lpx2) localizes to peroxisomes and interacts with Pex5, a receptor for peroxisomal matrix protein import .

  • Lipid Metabolism: Lipidomic analyses revealed that Δykl050c strains accumulate LPG, suggesting its role in phospholipid degradation .

  • Enzymatic Activity: YKL050C demonstrates hydrolytic activity against lipid substrates, positioning it as a therapeutic target for lipid-related disorders .

Experimental Validation

  • Western Blot: The antibody reliably detects YKL050C in yeast lysates, confirming its specificity .

  • Yeast-Two-Hybrid Assays: Validated interactions between YKL050C and peroxisomal import machinery components .

Table 1: Lipidomic Impact of Δykl050c in Glucose Media4

Lipid ClassChange in Δykl050c vs. Wild-Typep-value
Lyso-Phosphatidylglycerol (LPG)↑ 2.5-fold<0.01
Triacylglycerol (TAG)↓ 1.8-fold<0.05

Table 2: YKL050C Antibody Performance3

ApplicationDilution RangeValidation Status
ELISA1:1,000–1:5,000Confirmed
WB1:500–1:2,000Verified

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YKL050C antibody; YKL263 antibody; YKL301 antibody; Uncharacterized protein YKL050C antibody
Target Names
YKL050C
Uniprot No.

Q&A

What is YKL050C and why is it studied in research?

YKL050C is a protein found in Saccharomyces cerevisiae (Baker's yeast), specifically in strain ATCC 204508 / S288c, associated with UniProt accession number P35736 . The protein serves as an important target in basic yeast research to understand fundamental cellular processes in this model organism. Antibodies against YKL050C provide valuable tools for detecting, quantifying, and studying this protein in various experimental contexts. The applications include protein expression analysis, protein localization studies, and investigation of protein-protein interactions within yeast cells. YKL050C research contributes to our broader understanding of eukaryotic cellular mechanisms, as S. cerevisiae often serves as a model system for more complex organisms.

What applications is YKL050C antibody suitable for?

YKL050C antibody has been specifically tested and validated for applications including ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) to ensure accurate identification of the antigen . These techniques allow researchers to detect and quantify YKL050C protein in different experimental settings. For ELISA applications, the antibody enables quantification of YKL050C in solution, while Western Blot applications facilitate detection of the protein in cell lysates separated by gel electrophoresis. The polyclonal nature of this antibody provides recognition of multiple epitopes on the YKL050C protein, potentially increasing detection sensitivity compared to monoclonal antibodies that recognize only a single epitope. Researchers should always validate the antibody in their specific experimental system for optimal results.

What are the optimal storage conditions for YKL050C antibody?

The YKL050C antibody requires storage at either -20°C or -80°C upon receipt to maintain its activity and specificity . The antibody is supplied in liquid formulation containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This formulation helps maintain antibody stability during freeze-thaw cycles, though repeated freeze-thaw should be avoided to prevent degradation of the antibody . For working solutions needed within one week, short-term storage at 4°C is acceptable. Best practices include aliquoting the antibody into smaller volumes before freezing to minimize freeze-thaw cycles. Proper adherence to these storage guidelines is crucial for maintaining antibody functionality and ensuring reliable, reproducible experimental results.

How do researchers verify YKL050C antibody specificity?

Verifying YKL050C antibody specificity requires a systematic validation approach involving multiple controls and techniques:

  • Positive control analysis using purified recombinant YKL050C protein to confirm specific binding

  • Negative control testing with YKL050C knockout or depleted yeast samples to evaluate background signal

  • Western blot analysis to confirm detection of a single band at the expected molecular weight

  • Cross-reactivity assessment against closely related yeast proteins to determine antibody exclusivity

  • Pre-absorption controls using excess antigen to confirm signal elimination through specific binding

Additional validation can include immunoprecipitation followed by mass spectrometry analysis to confirm the identity of the pulled-down protein. For advanced structural characterization, techniques like cryoEM can be employed to map epitope binding sites . Complete validation ensures that experimental results accurately reflect YKL050C biology rather than artifacts from non-specific interactions or cross-reactivity with other yeast proteins.

What is the difference between polyclonal and monoclonal antibodies for YKL050C detection?

The YKL050C antibody available for research is a polyclonal antibody produced in rabbits . This classification has significant implications for its research applications:

CharacteristicPolyclonal YKL050C AntibodyMonoclonal Antibodies
ProductionMultiple B-cell lineages in immunized rabbitSingle B-cell clone
Epitope recognitionMultiple epitopes on YKL050CSingle epitope
SensitivityGenerally higher due to multiple binding sitesPotentially lower but more consistent
Batch-to-batch variationModerate to highMinimal
Application flexibilityWorks across multiple applicationsMay be optimized for specific applications
Denaturation toleranceHigher tolerance to protein denaturationMay lose binding if epitope is altered

How can researchers optimize Western blot protocols for YKL050C detection?

Optimizing Western blot protocols for YKL050C detection requires careful attention to multiple parameters:

Sample Preparation:

  • Extract yeast proteins using mechanical disruption (glass beads) or enzymatic methods (zymolyase)

  • Include protease inhibitor cocktail to prevent YKL050C degradation

  • Maintain samples at 4°C during processing

  • Denature proteins completely in SDS loading buffer at 95°C for 5 minutes

Gel Electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Load 20-50 μg total protein per lane (optimize based on YKL050C expression level)

  • Include positive control (known YKL050C-expressing sample)

  • Run gel at 100-120V until adequate separation is achieved

Transfer Conditions:

  • Use PVDF membrane (0.45 μm pore size) for better protein retention

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with reversible protein stain

Antibody Incubation:

  • Block membrane with 5% non-fat dry milk or 3% BSA in TBST for 1 hour at room temperature

  • Dilute YKL050C antibody according to manufacturer recommendations (typically 1:1000-1:2000)

  • Incubate with primary antibody overnight at 4°C with gentle rocking

  • Wash membrane extensively with TBST (4-5 times, 5-10 minutes each)

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour

Detection and Documentation:

  • Develop using enhanced chemiluminescence (ECL) substrate

  • Optimize exposure time to avoid signal saturation

  • Document results with digital imaging system for quantitative analysis

This optimized protocol provides a methodological framework that researchers can adapt based on their specific experimental conditions and equipment.

How can cryoEM techniques characterize YKL050C antibody-antigen interactions?

CryoEM (cryogenic electron microscopy) offers advanced structural insights into YKL050C antibody-antigen interactions at near-atomic resolution. Based on similar approaches in antibody research , a methodological workflow would include:

  • Complex Formation:

    • Purify recombinant YKL050C protein to >95% homogeneity

    • Generate Fab fragments from YKL050C antibody using papain digestion

    • Form stable antibody-antigen complexes using 3:1 molar ratio of Fab to antigen

    • Purify complexes by size exclusion chromatography

  • CryoEM Sample Preparation:

    • Apply 3-4 μL purified complex to glow-discharged grids

    • Blot excess solution (4-5 seconds) and plunge-freeze in liquid ethane

    • Store grids in liquid nitrogen until imaging

  • Data Collection and Processing:

    • Collect micrographs using direct electron detector with dose fractionation

    • Process image stacks with motion correction and CTF estimation

    • Perform particle picking, 2D classification, and 3D reconstruction

    • Refine the 3D structure to high resolution (ideally <4Å)

  • Epitope Mapping and Model Building:

    • Build atomic models into reconstructed density maps

    • Identify specific amino acid residues at antibody-antigen interface

    • Validate interactions through mutagenesis or cross-linking studies

  • Binding Affinity Characterization:

    • Complement structural data with kinetic measurements using biolayer interferometry (BLI)

    • Determine association/dissociation rates and equilibrium dissociation constant (Kd)

This approach provides detailed molecular understanding of antibody specificity, potentially revealing conformational epitopes and binding mechanisms that inform experimental design and interpretation.

What factors influence YKL050C epitope accessibility in different experimental applications?

Epitope accessibility significantly affects YKL050C antibody binding efficiency across different experimental applications. Researchers must consider several determinants:

Protein Conformation Influences:

  • Native vs. denatured conditions alter epitope exposure

  • Reducing agents (β-mercaptoethanol, DTT) disrupt disulfide bonds, potentially revealing hidden epitopes

  • Applications requiring native protein (immunoprecipitation) may experience reduced antibody binding if epitopes are conformationally masked

Sample Preparation Effects:

  • Fixation methods (formaldehyde, methanol) can alter protein structure and epitope accessibility

  • Heat-induced antigen retrieval may recover epitopes masked by fixation

  • Detergent selection affects membrane protein solubilization and epitope exposure

Application-Specific Considerations:

ApplicationKey Accessibility FactorsOptimization Approaches
Western BlotComplete denaturation for linear epitope accessSDS and heat treatment, reducing conditions
ImmunoprecipitationPreserving native structure while exposing epitopesGentle non-ionic detergents, salt optimization
ELISAConsistent antigen coating and presentationOptimize coating buffer pH, blocking conditions
ImmunofluorescenceFixation and permeabilization balanceTest multiple fixatives, antigen retrieval methods

Environmental Variables:

  • Buffer pH alters protein charge distribution and conformation

  • Ionic strength affects antibody-antigen interaction strength

  • Temperature influences both protein conformation and binding kinetics

Systematic optimization of these parameters is essential for maximizing specific detection while minimizing background signal. Researchers should document conditions that successfully expose YKL050C epitopes for each application.

What troubleshooting approaches address inconsistent YKL050C antibody results?

When facing inconsistent results with YKL050C antibody, a methodical troubleshooting approach is essential:

Antibody Quality Assessment:

  • Verify antibody integrity by checking expiration date and storage history

  • Test activity using dot blot with purified antigen

  • Consider antibody degradation if multiple freeze-thaw cycles have occurred

  • Compare results between different antibody lots if available

Sample Preparation Evaluation:

  • Confirm complete cell lysis and protein extraction

  • Assess protein degradation using Coomassie staining of total protein

  • Add additional protease inhibitors if degradation is suspected

  • Verify sample concentration and loading consistency

Protocol Optimization Matrix:

ParameterTest RangeEvaluation Method
Antibody Dilution1:500 to 1:5000Signal-to-noise ratio
Blocking AgentMilk vs. BSA vs. CaseinBackground reduction
Incubation Time1h to overnightSignal intensity
Washing Stringency3-6 washes, 5-15 min eachBackground reduction
Detection MethodChemiluminescence vs. fluorescenceSensitivity and linearity

Application-Specific Troubleshooting:

  • For Western blot: Optimize transfer conditions, membrane type

  • For ELISA: Adjust coating concentration, blocking formulation

  • For IP: Test different lysis buffers, bead types

Systematic Documentation:

  • Create a detailed troubleshooting log recording all variables

  • Test one parameter at a time to identify critical factors

  • Document successful conditions for future reference

Through this systematic approach, researchers can identify sources of variability and establish reliable protocols for consistent YKL050C detection across experiments.

How should co-immunoprecipitation experiments with YKL050C antibody be designed?

Designing effective co-immunoprecipitation (co-IP) experiments with YKL050C antibody requires careful consideration of experimental conditions to preserve protein-protein interactions while ensuring specific isolation:

Experimental Design Considerations:

  • Lysis Optimization:

    • Use gentle lysis buffers to preserve interactions (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40)

    • Include protease inhibitor cocktail to prevent degradation

    • Perform lysis at 4°C to minimize protein denaturation

  • Antibody Binding Strategy:

    • Pre-bind YKL050C antibody to protein A/G beads (2-5 μg antibody per experiment)

    • Pre-clear lysates with beads alone to reduce non-specific binding

    • Optimize antibody-to-lysate ratio for maximum specific pull-down

  • Control Implementation:

    Control TypePurposeImplementation
    Negative ControlAssess non-specific bindingIP with non-specific rabbit IgG
    Input ControlVerify protein presenceAnalyze 5-10% of pre-IP lysate
    Specificity ControlConfirm antibody specificityCompete with excess antigen
    Reciprocal IPValidate interactionsIP with antibodies against binding partners
  • Interaction Preservation:

    • Optimize salt concentration (100-300 mM) to balance specificity with interaction maintenance

    • Test different detergents (NP-40, Triton X-100, Digitonin) for optimal solubilization

    • Consider chemical crosslinking for transient interactions

  • Detection Methods:

    • Western blot for targeted detection of suspected binding partners

    • Mass spectrometry for unbiased identification of all co-precipitated proteins

    • Validation with reciprocal co-IP or proximity ligation assay

  • Data Analysis:

    • Quantify enrichment relative to negative controls

    • Determine reproducibility across biological replicates

    • Validate key interactions with orthogonal methods

This methodological framework provides a systematic approach to identifying YKL050C protein interaction partners while minimizing artifacts from non-specific binding or post-lysis interactions.

How can researchers integrate YKL050C antibody with advanced structural biology techniques?

Integrating YKL050C antibody with advanced structural biology techniques enables comprehensive characterization of protein structure, function, and interactions:

CryoEM Integration:

  • Use YKL050C antibody fragments (Fab) as fiducial markers for orientation determination in cryoEM

  • Apply cryoEM polyclonal epitope mapping (cryoEMPEM) to identify antibody binding sites

  • Generate 3D reconstructions of antibody-antigen complexes at near-atomic resolution

  • Build atomic models into density maps to visualize binding interfaces

Structural Mapping Workflow:

  • Generate and validate antibody-antigen complexes

  • Collect high-resolution cryoEM data

  • Process data using classification algorithms to separate heterogeneous populations

  • Perform 3D reconstruction and model building

  • Annotate epitopes and interaction surfaces

Integrative Structural Approaches:

TechniqueInformation ProvidedIntegration with Antibody
X-ray CrystallographyAtomic resolution structureCo-crystallization with Fab fragments
Hydrogen-Deuterium ExchangeSolvent accessibility, dynamicsCompare exchange rates with/without antibody
Cross-linking Mass SpectrometrySpatial proximity of residuesIdentify residues protected by antibody binding
Small-Angle X-ray ScatteringSolution-state molecular envelopeValidate complex formation and conformation

Advanced Applications:

  • Epitope mapping through negative-stain electron microscopy followed by cryoEM refinement

  • Combining computational modeling with experimental validation of antibody-antigen interfaces

  • Using antibodies to stabilize flexible regions for structural determination

  • Correlating structural information with functional assays to connect structure to function

This integrative approach leverages YKL050C antibody beyond traditional applications, providing deeper molecular insights into protein structure and function in the context of the cellular environment.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.